Author

Álvaro Muñoz

Observed names: A Muñoz, A. Muñoz, A., Muñoz, Alvaro Muñoz, Á Muñoz, Á. Muñoz

Institutions: Iberia (Spain), Pharmacoeconomics and Health Outcomes Research Iberia (Spain)

Observed institutions: Iberia (Spain), Pharmacoeconomics and Health Outcomes Research Iberia (Spain)

ORCID: 0000-0003-0896-1423

Observed ORCID: 0000-0003-0896-1423

OpenAlex ID: A5102738097

Cost, Time, and Error Assessment During Preparation of Parenteral Nutrition: Multichamber Bags Versus Hospital‐Compounded Bags

2018 · David Berlana, M. Asunción Almendral, et al. · Journal of Parenteral and Enteral Nutrition · 46

Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective

2024 · Luis Pablo, Gonzaga Garay-Aramburu, et al. · Health Economics Review · 16

Perception of a New Prolonged-Release Buprenorphine Formulation in Patients with Opioid Use Disorder: The PREDEPO Study

2021 · Francisco Salvador Pascual, Alvaro Muñoz, et al. · European Addiction Research · 8

Patient Preferences for Pharmacological Diabetes Treatment Among People with Diabetes in Spain: A Discrete Choice Experiment

2021 · Fernando Gómez-Peralta, María Mareque, et al. · Diabetes Therapy · 6

Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study

2024 · Esther Chamorro-de-Vega, Alberto Calvo, et al. · Farmacia Hospitalaria · 4

Evaluation of the hospital care quality perceived by patients with immune‐mediated inflammatory diseases from the pharmacy service. SACVINFA study

2022 · Esther Ramírez, Rosa Romero‐Jiménez, et al. · Journal of Clinical Pharmacy and Therapeutics · 4

Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study

2018 · A Ocampo, P Domingo, et al. · Journal of Antimicrobial Chemotherapy · 4

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study

2019 · D. Podzamczer, N. Rozas, et al. · Current HIV Research · 3

CO22 Use of Ixekizumab for Psoriatic Arthritis Patients in Real-World Conditions

2022 · B Joven, R Hernández Sánchez, et al. · Value in Health · 2

Pmh70 Direct Healthcare Costs for the Management of Patients With Opioid Use Disorder Treated With Methadone and Buprenorphine/naloxone in Real-world Setting in Spain. Costedopia Study

2019 · C. Roncero, M.L. Dorado, et al. · Value in Health · 1

P1595: Ifistrategy: a Spanish National Survey on Strategies for Management of Invasive Fungal Infection and Guidelines Application in High Risk Onco-hematological Patients

2022 · C. Vallejo, I. Jarque, et al. · HemaSphere

POSA331 Patient Preferences for Diabetes Management in Spain - A Discrete Choice Experiment

2022 · Á Muñoz, F Gómez-Peralta, et al. · Value in Health

Supplementary Material for: Perception of a New Prolonged-Release Buprenorphine Formulation in Patients with Opioid Use Disorder: The PREDEPO Study

2021 · F.S., Pascual, A., Muñoz, et al. · Figshare

Works count: 13

Citation count: 92

H-index: 4

I10-index: 2